目录肽产品
CANS-012A
Pep-1L-NOTA
H-Ala-Cys-Gly-Glu-Met-Gly-Trp-Val-Arg-Cys-Gly-Gly-Gly-Ser-C6-Lys-Lys(NOTA)-NH2 (trifluoroacetate salt)\r\n(Reduced Cys-H)
H-Ala-Cys-Gly-Glu-Met-Gly-Trp-Val-Arg-Cys-Gly-Gly-Gly-Ser-C6-Lys-Lys(NOTA)-NH2 (trifluoroacetate salt)\r\n(Reduced Cys-H)
Size：1.0
P1(RMB)：2380
MW：2023.36
One letter sequence：ACGEMGWVRCGGGS-C6-K-K(NOTA)-NH2
Molecular Formula：C84H139N27O25S3
Description：Metal chelating peptide Pep-1L-NOTA targets tumor-restricted receptor, IL13RA2, found to be present in some aggressive malignancies, specifically gliomas and malignant melanoma. Recent work has demonstrated that the copper-bound peptide selectively binds hIL13RA2-expressing tumors and validates its use in peptide-based PET imaging for cancer diagnostics.
Literature Reference：Sai, Kiran Kumar Solingapuram, et al. \"Peptide-based PET imaging of the tumor restricted IL13RA2 biomarker.\" Oncotarget 5 (2017).
Cas：
P1(RMB)：2380
MW：2023.36
One letter sequence：ACGEMGWVRCGGGS-C6-K-K(NOTA)-NH2
Molecular Formula：C84H139N27O25S3
Description：Metal chelating peptide Pep-1L-NOTA targets tumor-restricted receptor, IL13RA2, found to be present in some aggressive malignancies, specifically gliomas and malignant melanoma. Recent work has demonstrated that the copper-bound peptide selectively binds hIL13RA2-expressing tumors and validates its use in peptide-based PET imaging for cancer diagnostics.
Literature Reference：Sai, Kiran Kumar Solingapuram, et al. \"Peptide-based PET imaging of the tumor restricted IL13RA2 biomarker.\" Oncotarget 5 (2017).
Cas：
